首页> 外国专利> Methods of using the FRI domain of human frizzled receptor for inhibiting Wnt signaling in a tumor or tumor cell

Methods of using the FRI domain of human frizzled receptor for inhibiting Wnt signaling in a tumor or tumor cell

机译:使用人卷曲的受体的FRI结构域抑制肿瘤或肿瘤细胞中Wnt信号转导的方法

摘要

The present invention relates to compositions and methods for characterizing, diagnosing, and treating cancer. In particular the invention provides the means and methods for the diagnosis, characterization, prognosis and treatment of cancer and specifically targeting cancer stem cells. The present invention provides a soluble FZD receptor comprising an extracellular domain of a human FZD receptor that inhibits growth of tumor cells. The present invention still further provides a soluble receptor comprising a Fri domain of a human FZD receptor that binds a ligand of a human FZD receptor and said soluble receptor is capable of inhibiting tumor growth. The present invention still further provides a method of treating cancer comprising administering a soluble FZD receptor comprising for example, either an extracellular domain of a human FZD receptor or a Fri domain of a human FZD receptor, in an amount effective to inhibit tumor growth.
机译:本发明涉及用于表征,诊断和治疗癌症的组合物和方法。特别地,本发明提供了用于诊断,表征,预后和治疗癌症并且特别靶向癌症干细胞的手段和方法。本发明提供了包含抑制肿瘤细胞生长的人FZD受体的胞外域的可溶性FZD受体。本发明进一步提供了一种可溶性受体,其包含与人FZD受体的配体结合的人FZD受体的Fri结构域,并且所述可溶性受体能够抑制肿瘤生长。本发明还进一步提供了一种治疗癌症的方法,该方法包括以有效抑制肿瘤生长的量施用可溶性FZD受体,其包括例如人FZD受体的细胞外结构域或人FZD受体的Fri结构域。

著录项

  • 公开/公告号US9228013B2

    专利类型

  • 公开/公告日2016-01-05

    原文格式PDF

  • 申请/专利权人 ONCOMED PHARMACEUTICALS INC.;

    申请/专利号US201414266998

  • 申请日2014-05-01

  • 分类号C07K16/28;C07K14/705;A61K38;A61K45/06;A61K47/48;C07K14/72;C07K16;G01N33/574;C07K16/18;A61K39;

  • 国家 US

  • 入库时间 2022-08-21 14:27:58

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号